Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies. (2014)
Attributed to:
Development and comparative evaluation of three new generation BRSV DIVA vaccines and a corresponding DIVA test
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0100392
PubMed Identifier: 24945377
Publication URI: http://europepmc.org/abstract/MED/24945377
Type: Journal Article/Review
Volume: 9
Parent Publication: PloS one
Issue: 6
ISSN: 1932-6203